# Guanfacine - Alpha-2 adrenergic agonist
# Approved in US, EU, Japan; not available in China

id: "guanfacine"

brandNames:
  US: ["Intuniv", "Tenex"]
  CN: []
  EU: ["Intuniv"]
  JP: ["インチュニブ (Intuniv)"]
  UK: ["Intuniv"]
  AU: ["Intuniv"]
  CA: ["Intuniv"]

genericName:
  en: "guanfacine hydrochloride"
  zh: "盐酸胍法辛"
  ja: "グアンファシン塩酸塩"

manufacturers:
  - name: "Takeda (formerly Shire)"
    region: "US"
    product: "Intuniv"
  - name: "Shionogi"
    region: "JP"
    product: "インチュニブ"

# Classification
drugClass: "non-stimulant"

drugClassLabel:
  en: "Non-Stimulant"
  zh: "非兴奋剂"
  ja: "非中枢刺激薬"

category: "alpha-2 adrenergic agonist"

categoryLabel:
  en: "Alpha-2 Adrenergic Agonist"
  zh: "α-2肾上腺素能激动剂"
  ja: "α2アドレナリン受容体作動薬"
controlledSubstance: false
schedule:
  US: "Not scheduled"
  CN: "Not approved"
  EU: "Not scheduled"
  JP: "Not scheduled"
  UK: "Not scheduled"

# Mechanism
activeIngredient:
  en: "guanfacine hydrochloride"
  zh: "盐酸胍法辛"
  ja: "グアンファシン塩酸塩"

mechanismOfAction:
  en: "Selective alpha-2A adrenergic receptor agonist. Stimulates receptors in the prefrontal cortex, strengthening working memory, reducing distractibility, and improving impulse control. Also has calming effect by reducing sympathetic outflow."
  zh: "选择性α-2A肾上腺素能受体激动剂。刺激前额叶皮层的受体，增强工作记忆，减少分心，改善冲动控制。还通过减少交感神经传出而具有镇静作用。"
  ja: "選択的α2Aアドレナリン受容体作動薬。前頭前皮質の受容体を刺激し、ワーキングメモリを強化し、気が散りやすさを軽減し、衝動制御を改善します。また、交感神経出力を減少させることで鎮静効果もあります。"
neurotransmittersAffected:
  - norepinephrine

# Dosage & Forms
forms:
  - type: "tablet"
    typeLabel:
      en: "Tablet"
      zh: "片剂"
      ja: "錠剤"
    releaseType: "extended"
    releaseTypeLabel:
      en: "Extended Release"
      zh: "缓释"
      ja: "徐放性"
    brandName: "Intuniv"
    strengths: ["1mg", "2mg", "3mg", "4mg"]
    durationHours: 24
    notes:
      en: "Extended-release for ADHD; must swallow whole"
      zh: "ADHD缓释制剂；需整片吞服"
      ja: "ADHD用徐放製剤；そのまま飲み込む必要あり"

  - type: "tablet"
    typeLabel:
      en: "Tablet"
      zh: "片剂"
      ja: "錠剤"
    releaseType: "immediate"
    releaseTypeLabel:
      en: "Immediate Release"
      zh: "速释"
      ja: "即放性"
    brandName: "Tenex"
    strengths: ["1mg", "2mg"]
    durationHours: 8-12
    notes:
      en: "Immediate-release; originally for hypertension; not FDA-approved for ADHD"
      zh: "速释制剂；最初用于高血压；未获FDA批准用于ADHD"
      ja: "即放性製剤；元々は高血圧用；ADHDにはFDA未承認"

# Efficacy
onsetMinutes: null  # Gradual effect over weeks
peakEffectHours: 5
durationHours: 24

# Side Effects
sideEffects:
  common:
    - name:
        en: "somnolence/fatigue"
        zh: "嗜睡/疲劳"
        ja: "傾眠/疲労"
      frequency: "30-40%"
    - name:
        en: "headache"
        zh: "头痛"
        ja: "頭痛"
      frequency: "20-25%"
    - name:
        en: "dizziness"
        zh: "头晕"
        ja: "めまい"
      frequency: "10-15%"
    - name:
        en: "decreased appetite"
        zh: "食欲下降"
        ja: "食欲減退"
      frequency: "10-15%"
    - name:
        en: "abdominal pain"
        zh: "腹痛"
        ja: "腹痛"
      frequency: "10%"
    - name:
        en: "dry mouth"
        zh: "口干"
        ja: "口渇"
      frequency: "10%"
    - name:
        en: "nausea"
        zh: "恶心"
        ja: "悪心"
      frequency: "5-10%"
    - name:
        en: "constipation"
        zh: "便秘"
        ja: "便秘"
      frequency: "5%"

  uncommon:
    - name:
        en: "hypotension"
        zh: "低血压"
        ja: "低血圧"
      frequency: "5-10%"
    - name:
        en: "bradycardia"
        zh: "心动过缓"
        ja: "徐脈"
      frequency: "5%"
    - name:
        en: "irritability"
        zh: "易怒"
        ja: "易刺激性"
      frequency: "5%"
    - name:
        en: "insomnia"
        zh: "失眠"
        ja: "不眠"
      frequency: "5%"

  serious:
    - name:
        en: "hypotension"
        zh: "低血压"
        ja: "低血圧"
      notes:
        en: "Can cause significant drops in blood pressure"
        zh: "可导致血压明显下降"
        ja: "血圧の著しい低下を引き起こす可能性"
    - name:
        en: "bradycardia"
        zh: "心动过缓"
        ja: "徐脈"
      notes:
        en: "May slow heart rate"
        zh: "可能减慢心率"
        ja: "心拍数を低下させる可能性"
    - name:
        en: "syncope"
        zh: "晕厥"
        ja: "失神"
      notes:
        en: "Fainting due to blood pressure drop"
        zh: "因血压下降导致昏厥"
        ja: "血圧低下による失神"
    - name:
        en: "rebound hypertension"
        zh: "反跳性高血压"
        ja: "リバウンド高血圧"
      notes:
        en: "If stopped abruptly; must taper"
        zh: "突然停药时发生；需逐渐减量"
        ja: "急に中止した場合；漸減が必要"
    - name:
        en: "sedation"
        zh: "镇静"
        ja: "鎮静"
      notes:
        en: "Can be severe, especially initially"
        zh: "可能很严重，尤其是在初期"
        ja: "特に初期は重度になる可能性"

# Safety
contraindications:
  en:
    - "Hypersensitivity to guanfacine"
    - "Severe bradycardia"
    - "Heart block"
  zh:
    - "对胍法辛过敏"
    - "严重心动过缓"
    - "心脏传导阻滞"
  ja:
    - "グアンファシンに対する過敏症"
    - "重度の徐脈"
    - "心ブロック"

drugInteractions:
  - drug:
      en: "CYP3A4 inhibitors (ketoconazole)"
      zh: "CYP3A4抑制剂（酮康唑）"
      ja: "CYP3A4阻害剤（ケトコナゾール）"
    severity: "moderate"
    effect:
      en: "Increased guanfacine levels"
      zh: "胍法辛血药浓度升高"
      ja: "グアンファシン濃度の上昇"
  - drug:
      en: "CYP3A4 inducers (rifampin)"
      zh: "CYP3A4诱导剂（利福平）"
      ja: "CYP3A4誘導剤（リファンピン）"
    severity: "moderate"
    effect:
      en: "Decreased guanfacine levels"
      zh: "胍法辛血药浓度降低"
      ja: "グアンファシン濃度の低下"
  - drug:
      en: "Antihypertensives"
      zh: "降压药"
      ja: "降圧薬"
    severity: "moderate"
    effect:
      en: "Additive hypotensive effect"
      zh: "降压作用叠加"
      ja: "降圧作用の相加"
  - drug:
      en: "CNS depressants"
      zh: "中枢神经抑制剂"
      ja: "中枢神経抑制剤"
    severity: "moderate"
    effect:
      en: "Enhanced sedation"
      zh: "镇静作用增强"
      ja: "鎮静作用の増強"
  - drug:
      en: "Valproic acid"
      zh: "丙戊酸"
      ja: "バルプロ酸"
    severity: "moderate"
    effect:
      en: "Increased guanfacine exposure"
      zh: "胍法辛暴露量增加"
      ja: "グアンファシン曝露量の増加"

blackBoxWarnings:
  en: []
  zh: []
  ja: []

pregnancyCategory: "B"

foodInteractions:
  en: "Avoid high-fat meals (increases absorption); avoid grapefruit juice"
  zh: "避免高脂肪餐（增加吸收）；避免葡萄柚汁"
  ja: "高脂肪食を避ける（吸収が増加）；グレープフルーツジュースを避ける"

# Practical Information
typicalDosing:
  children:
    startingDose: "1mg once daily"
    maxDose: "4mg/day (children 6-12) or 7mg/day (adolescents)"
    notes:
      en: "Increase by 1mg weekly; take at same time daily (morning or evening)"
      zh: "每周增加1mg；每天同一时间服用（早上或晚上）"
      ja: "毎週1mgずつ増量；毎日同じ時間に服用（朝または夕方）"
  adults:
    startingDose: "1mg once daily"
    maxDose: "4mg/day (off-label for adults)"
    notes:
      en: "Not FDA-approved for adult ADHD but commonly used"
      zh: "未获FDA批准用于成人ADHD但常用"
      ja: "成人ADHDにはFDA未承認だが一般的に使用される"

costEstimate:
  US:
    brand: "$300-400/month"
    generic: "$50-100/month"
  CN:
    brand: "Not available"
    generic: "Not available"

storageRequirements:
  en: "Room temperature (25°C), protect from light and moisture"
  zh: "室温保存（25°C），避光避湿"
  ja: "室温（25°C）で保存、光と湿気を避ける"

# Approval & Availability
approvals:
  - region: "US"
    agency: "FDA"
    year: 2009
    approvedAges:
      en: "6-17 years"
      zh: "6-17岁"
      ja: "6〜17歳"
    indications:
      en: ["ADHD"]
      zh: ["注意缺陷多动障碍"]
      ja: ["ADHD"]
    available: true
    notes:
      en: "Approved for children/adolescents; off-label for adults; can be used alone or with stimulants"
      zh: "批准用于儿童/青少年；成人为超说明书使用；可单独使用或与兴奋剂联用"
      ja: "小児/青年に承認；成人は適応外使用；単独または刺激薬との併用が可能"

  - region: "CN"
    agency: "NMPA"
    year: null
    approvedAges:
      en: ""
      zh: ""
      ja: ""
    indications:
      en: []
      zh: []
      ja: []
    available: false
    notes:
      en: "Not approved in China"
      zh: "中国未批准"
      ja: "中国では未承認"

  - region: "EU"
    agency: "EMA"
    year: 2015
    approvedAges:
      en: "6-17 years"
      zh: "6-17岁"
      ja: "6〜17歳"
    indications:
      en: ["ADHD"]
      zh: ["注意缺陷多动障碍"]
      ja: ["ADHD"]
    available: true
    notes:
      en: "First ADHD medication approved through EMA centralized procedure"
      zh: "首个通过EMA集中审批程序批准的ADHD药物"
      ja: "EMA集中審査手続きを通じて承認された最初のADHD薬"

  - region: "JP"
    agency: "PMDA"
    year: 2017
    approvedAges:
      en: "6-17 years"
      zh: "6-17岁"
      ja: "6〜17歳"
    indications:
      en: ["ADHD"]
      zh: ["注意缺陷多动障碍"]
      ja: ["ADHD"]
    available: true
    notes:
      en: "No registration requirement (unlike stimulants)"
      zh: "无需登记（与兴奋剂不同）"
      ja: "登録要件なし（刺激薬とは異なる）"

  - region: "UK"
    agency: "MHRA"
    year: 2016
    approvedAges:
      en: "6-17 years"
      zh: "6-17岁"
      ja: "6〜17歳"
    indications:
      en: ["ADHD"]
      zh: ["注意缺陷多动障碍"]
      ja: ["ADHD"]
    available: true
    notes:
      en: ""
      zh: ""
      ja: ""

  - region: "AU"
    agency: "TGA"
    year: 2013
    approvedAges:
      en: "6-17 years"
      zh: "6-17岁"
      ja: "6〜17歳"
    indications:
      en: ["ADHD"]
      zh: ["注意缺陷多动障碍"]
      ja: ["ADHD"]
    available: true
    notes:
      en: ""
      zh: ""
      ja: ""

  - region: "CA"
    agency: "Health Canada"
    year: 2013
    approvedAges:
      en: "6-17 years"
      zh: "6-17岁"
      ja: "6〜17歳"
    indications:
      en: ["ADHD"]
      zh: ["注意缺陷多动障碍"]
      ja: ["ADHD"]
    available: true
    notes:
      en: ""
      zh: ""
      ja: ""

# Special Considerations
specialConsiderations:
  cardiacRisk:
    en: "Can lower blood pressure and heart rate; use caution with cardiac conditions"
    zh: "可降低血压和心率；有心脏病者需谨慎"
    ja: "血圧と心拍数を低下させる可能性；心臓疾患には注意"
  abuseRisk:
    en: "No abuse potential; not a controlled substance"
    zh: "无滥用风险；非管制药物"
    ja: "乱用の可能性なし；規制物質ではない"
  withdrawalNotes:
    en: "MUST TAPER - stopping abruptly can cause rebound hypertension"
    zh: "必须逐渐减量 - 突然停药可导致反跳性高血压"
    ja: "必ず漸減すること - 急な中止はリバウンド高血圧を引き起こす可能性"
  monitoringRequired:
    en: "Blood pressure, heart rate; especially when starting or changing dose"
    zh: "血压、心率；尤其是开始用药或调整剂量时"
    ja: "血圧、心拍数；特に開始時または用量変更時"

# Travel Rules
travelRules:
  generalAdvice:
    en: "Guanfacine is NOT a controlled substance, making travel straightforward. However, it's not available in all countries (notably China). Carry prescription documentation."
    zh: "胍法辛不是管制药物，旅行较为简单。但并非所有国家都有供应（特别是中国）。请携带处方文件。"
    ja: "グアンファシンは規制物質ではないため、旅行は簡単です。ただし、すべての国で入手できるわけではありません（特に中国）。処方書類を携帯してください。"

  requiredDocumentation:
    - type: "prescription"
      typeLabel:
        en: "Valid prescription"
        zh: "有效处方"
        ja: "有効な処方箋"
      notes:
        en: "Recommended for longer trips"
        zh: "长途旅行建议携带"
        ja: "長期旅行の場合は推奨"

  maxPersonalSupply:
    default: "90 days"

  crossBorderRules:
    - fromRegion: "US"
      toRegion: "JP"
      status: "allowed"
      statusLabel:
        en: "Allowed"
        zh: "允许"
        ja: "許可"
      requirements:
        en:
          - "Carry prescription copy"
          - "Keep in original packaging"
        zh:
          - "携带处方副本"
          - "保持原包装"
        ja:
          - "処方箋のコピーを携帯"
          - "元のパッケージを維持"
      maxSupply: "90 days"
      notes:
        en: "Guanfacine is approved in Japan and is not a controlled substance. No special permit required."
        zh: "胍法辛在日本已获批且不是管制药物。无需特别许可。"
        ja: "グアンファシンは日本で承認されており、規制物質ではありません。特別な許可は不要です。"

    - fromRegion: "US"
      toRegion: "CN"
      status: "restricted"
      statusLabel:
        en: "Restricted - Not Available"
        zh: "受限 - 不可用"
        ja: "制限あり - 入手不可"
      requirements:
        en:
          - "Carry prescription and doctor's letter"
          - "Keep in original packaging"
        zh:
          - "携带处方和医生证明信"
          - "保持原包装"
        ja:
          - "処方箋と医師の手紙を携帯"
          - "元のパッケージを維持"
      maxSupply: "90 days"
      notes:
        en: "Guanfacine is NOT approved in China. You may bring personal supply but cannot obtain refills locally."
        zh: "胍法辛在中国未获批准。可以携带个人使用量，但无法在当地补充。"
        ja: "グアンファシンは中国では未承認です。個人使用分は持ち込めますが、現地での補充はできません。"

    - fromRegion: "US"
      toRegion: "EU"
      status: "allowed"
      statusLabel:
        en: "Allowed"
        zh: "允许"
        ja: "許可"
      requirements:
        en:
          - "Carry prescription copy"
        zh:
          - "携带处方副本"
        ja:
          - "処方箋のコピーを携帯"
      maxSupply: "90 days"
      notes:
        en: "Guanfacine is approved in EU. No special import requirements."
        zh: "胍法辛在欧盟已获批。无特殊进口要求。"
        ja: "グアンファシンはEUで承認されています。特別な輸入要件はありません。"

# Metadata
lastUpdated: 2025-12-02

sources:
  - "https://www.goodrx.com/conditions/adhd/non-stimulant-adhd-meds"
  - "https://www.ema.europa.eu/en/news/ema-recommends-approval-treatment-attention-deficit-hyperactivity-disorder"
  - "https://h-navi.jp/column/article/35028853"

notes:
  en: "Good option for hyperactivity/impulsivity symptoms or when stimulants cause anxiety. Particularly helpful for emotional dysregulation. Can be combined with stimulants. Must taper when discontinuing. Not approved for adult ADHD but commonly used off-label."
  zh: "适用于多动/冲动症状或兴奋剂引起焦虑时。对情绪失调特别有帮助。可与兴奋剂联用。停药时必须逐渐减量。未批准用于成人ADHD但常用于超说明书使用。"
  ja: "多動性/衝動性の症状、または刺激薬が不安を引き起こす場合に良い選択肢。感情調節障害に特に有用。刺激薬と併用可能。中止時は漸減が必要。成人ADHDには未承認だが適応外使用が一般的。"
